Dornase alfa - Cystic fibrosis
You are here : Home > Formulary Search > Dornase alfa - Cystic fibrosis
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Dornase alfa
Indication :
Cystic fibrosis
Group Name :
Keywords :
Brand Names Include :
Pulmozyme
Important Information :
NHSE Specialised Commissioned services only.
GPs may continue to prescribe for their EXISTING patients only. All new patients are commissioned by NHSE.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Other Indications
Below are listed other indications that Dornase alfa is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Cystic fibrosis.
Committee Recommendations (1)
01 Apr 13 -
Not Set
FOR NEW PATIENTS ONLY. Prescribing of Dornase Alfa will be considered RED on the Prescribing Adviisory database. Historically amber for Cystic Fibrosis patients via nebulisation / inhalation. Funding now rests with NHS England for this treatment.
FOR EXISTING PATIENTS: GPs should continue to prescribe these treatments. NHS England are looking to repatriate these patients in the future. The Medicines Management Team will be in contact with prescribers when they have more information
FOR EXISTING PATIENTS: GPs should continue to prescribe these treatments. NHS England are looking to repatriate these patients in the future. The Medicines Management Team will be in contact with prescribers when they have more information